KevinMD.com: Social media’s leading physician voice
The KevinMD newsletterReal physician voices, twice a weekFree, and one click to unsubscribe.
Subscribe free →

A new class of diabetes medication

Can it be hope for Merck? The selling point is no weight gain. Trials show a decrease of 0.77 in A1c over 12 weeks.

Share this articleLinkedInFacebookXEmail

Real physician voices, twice a week

Free, and one click to unsubscribe.

No spam. We never share your email.